— Includes SARS-CoV-2 Synthetic RNA Control with D614G Mutation — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of its infectious disease product line with the addition of 16 new synthetic controls […]
CAMBRIDGE, UK – Nuclera, a Cambridge, UK-based biotech company developing benchtop gene and protein printing technologies, is pleased to announce that Dr Joe Keegan has been appointed to its Board as Non-executive Director. Dr Keegan has more than 30 years of experience in life science businesses. He was CEO at ForteBio Inc, a life science tool […]
Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with the release of the miRNAscope™ Assay. The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization of single-molecule RNA with […]
A complete platform of instrumentation, software, and reagents for rapid fluorescence staining and 21-channel whole-slide imaging Seattle, WA. – RareCyte, Inc., a company focused on providing Precision Biology™ solutions for life sciences, announced today the Orion spatial biology analysis platform applicable to translational and clinical research. Orion is based on a patented and proprietary technology that […]
MERFISH Platform Illuminates Biology at the Nanoscale to Advance Discovery and Translational Research in Neuroscience, Immuno-Oncology, Infectious Disease/COVID-19 CAMBRIDGE, Mass. — Vizgen, the company developing the next generation of single-cell, spatial genomics profiling tools, today announced the launch of an Early Release Program for its novel MERFISH imaging platform. The program provides scientific investigators an opportunity […]
Arrayjet, the Scottish-based microarray instrumentation company has secured a further contract with US-based Proteomics company, CDI Laboratories, located in Baltimore, Maryland and Mayaguez, Puerto Rico which will further enhance CDI’s work in advancing proteomic research and development. The contract value is circa $1million and is the second Arrayjet install at CDI. As part of the deal […]
LEIDEN, The Netherlands — Toxys BV is a biotech company based in Leiden, The Netherlands, that provides innovative in vitro toxicity screening solutions to identify carcinogenic and other hazardous properties of compounds for the pharmaceutical, chemical, cosmetics and food industry. Today, Toxys announces the appointment of Susan Swarte as new non-executive member of the Board of Directors. Susan is […]
New BMC Genomics publication validates novel TruDrop approach developed in collaboration with scientists at Vanderbilt University Medical Center and RootPath Genomics WATERTOWN, Mass. – 1CellBio, Inc., announced today a new dual indexed library design capability that improves costs, throughput and data quality for its inDrop™ single-cell RNA sequencing (scRNA-seq) System. The TruDrop capability was developed in collaboration […]
Reduces genomic data storage and transfer costs associated with the data deluge In 2019, the volume of genomic data generated by Illumina’s global installed base of more than 15,000 sequencing systems increased more than 50 percent year-over-year, to 150 petabases. That is the equivalent of 500 years of continuous video recordings in high definition. This […]
CARLSBAD, Calif. — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays to Russian labs for […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
